Ilika moves Goliath cells into independent commercial testing

Ilika Plc

Ilika has supplied its 10 Ah Goliath battery cells to About:Energy for independent testing, marking a further step towards commercialisation.

The UK-developed pouch cells have a stated energy density of 300 Wh/kg. Ilika’s Gen1 model is the first quasi-solid-state cell to be tested by About:Energy and will be assessed for its suitability across a range of applications.

The results will be added to About:Energy’s Voltt battery database. This should give Ilika and potential customers a clearer view of how the Goliath technology compares with application requirements and where it may offer the strongest commercial fit.

Automotive stakeholders are already evaluating the 10 Ah prototypes. Ilika has also reported interest from the defence sector, where battery safety and secure domestic supply can be important purchasing factors.

The company is also working with Brompton on possible e-bike applications. This gives the technology exposure to a market where weight, energy density, safety and charging performance are central to product design.

Ilika has developed two versions of the Goliath cell. Gen1 uses the company’s proprietary quasi-solid electrolyte, while Gen1L uses a liquid electrolyte.

Both variants use a high-silicon-content anode and a high-nickel nickel manganese cobalt cathode. Gen1 has a stated continuous discharge rate of 3C, while Gen1L has a stated rate of 6C.

The two-cell approach allows Ilika to target different operating requirements. Gen1 is positioned around the potential safety and performance benefits of a quasi-solid electrolyte. Gen1L offers a higher continuous discharge rate and may suit applications that require greater power output.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Defence demand puts specialist battery technology in focus

Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions.

Battery & Energy Storage Tech Europe 2026 targets the next phase of industrial growth

Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market.

Ilika moves Goliath cells into independent commercial testing

Ilika has moved its UK-made Goliath cells into independent testing as it targets commercial opportunities in automotive, defence and e-bike markets.

Search